Search for other papers by Julia Ramalho Amalio da Silva Breder in
Google Scholar
PubMed
Search for other papers by Paulo Alonso Garcia Alves in
Google Scholar
PubMed
Search for other papers by Mario Lucio Araújo in
Google Scholar
PubMed
Search for other papers by Barbara Pires in
Google Scholar
PubMed
Search for other papers by Priscila Valverde in
Google Scholar
PubMed
Search for other papers by Daniel Alves Bulzico in
Google Scholar
PubMed
Search for other papers by Fernanda Andrade Accioly in
Google Scholar
PubMed
Search for other papers by Rossana Corbo in
Google Scholar
PubMed
Search for other papers by Mario Vaisman in
Google Scholar
PubMed
Endocrinology Department, Instituto Nacional do Cancer do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed
thyroid tumors ( 13 , 14 , 15 ). Although less frequently mentioned, the expression of progesterone receptors (PR) in DTC has also been described ( 13 , 14 , 15 ). Vannuchi et al. observed a positive correlation of tumor size and PR positivity ( 14
Search for other papers by Giacomo Sturniolo in
Google Scholar
PubMed
Search for other papers by Carles Zafon in
Google Scholar
PubMed
Search for other papers by Mariacarla Moleti in
Google Scholar
PubMed
Search for other papers by Josep Castellví in
Google Scholar
PubMed
Search for other papers by Francesco Vermiglio in
Google Scholar
PubMed
Search for other papers by Jordi Mesa in
Google Scholar
PubMed
of our study was to determine the immunohistochemical expression of ER-α and progesterone receptor (PR) in a large series of PTC patients, and to correlate the above expressions with epidemiological and clinical features. Patients and Methods
Search for other papers by Marine Sitbon in
Google Scholar
PubMed
Search for other papers by Porhuoy Chou in
Google Scholar
PubMed
Search for other papers by Seydou Bengaly in
Google Scholar
PubMed
Search for other papers by Brigitte Poirot in
Google Scholar
PubMed
Search for other papers by Marie Laloi-Michelin in
Google Scholar
PubMed
Search for other papers by Laure Deville in
Google Scholar
PubMed
Search for other papers by Atanas Pachev in
Google Scholar
PubMed
Search for other papers by Ahouefa Kowo-Bille in
Google Scholar
PubMed
Search for other papers by Clement Dumont in
Google Scholar
PubMed
Search for other papers by Cécile N Chougnet in
Google Scholar
PubMed
2, pT2N0, estrogen and progesterone receptor-positive, Her2-positive, Ki67 20%) by surgery and adjuvant chemotherapy (epirubicin, cyclophosphamide, docetaxel, trastuzumab) and anastrozole (until February 2019). In April 2019, she presented with
Search for other papers by Ilaria Muller in
Google Scholar
PubMed
Search for other papers by Lucy S. Kilburn in
Google Scholar
PubMed
Search for other papers by Peter N. Taylor in
Google Scholar
PubMed
Search for other papers by Peter J. Barrett-Lee in
Google Scholar
PubMed
Search for other papers by Judith M. Bliss in
Google Scholar
PubMed
Search for other papers by Paul Ellis in
Google Scholar
PubMed
Search for other papers by Marian E. Ludgate in
Google Scholar
PubMed
Search for other papers by Colin M. Dayan in
Google Scholar
PubMed
negative, negative HER2, ER, and progesterone receptor; WLE, wide local excision; 95% CI, 95% confidence interval. Fig. 3. Univariate analyses by autoantibodies to thyroid peroxidase (TPOAb) categorized into tertiles. Kaplan-Meier curves
Search for other papers by Estefanía Rinaldini in
Google Scholar
PubMed
Search for other papers by Fiorella Campo Verde Arboccó in
Google Scholar
PubMed
Search for other papers by Marcelo Ezquer in
Google Scholar
PubMed
Facultad de Ciencias Médicas, Instituto de Fisiología, Universidad Nacional de Cuyo, Mendoza, Argentina
Search for other papers by Carlos Gamarra-Luques in
Google Scholar
PubMed
Facultad de Ciencias Exactas y Naturales, Universidad Nacional de Cuyo, Mendoza, Argentina
Search for other papers by María Belén Hapon in
Google Scholar
PubMed
, Kuhn C , Hofmann S , Bayer B , . The expression of thyroid hormone receptors (THR) is regulated by the progesterone receptor system in first trimester placental tissue and in BeWo cells in vitro . Eur J Obstet Gynecol Reprod Biol . 2015 Dec ; 195
Search for other papers by R. Burns in
Google Scholar
PubMed
National Maternity Hospital, Dublin, Ireland
Search for other papers by C. O'Herlihy in
Google Scholar
PubMed
Search for other papers by P.P.A. Smyth in
Google Scholar
PubMed
of estrogen, receptors in the developing human placenta. Horm Metab Res 1997;29:604-610. 10.1055/s-2007-979109 9497895 33 Shanker YG, Rao AJ: Progesterone receptor expression in the human placenta. Mol Hum Reprod 1999;5:481-486. 10.1093/molehr
Search for other papers by Sepehr Torabinejad in
Google Scholar
PubMed
Search for other papers by Caterina Miro in
Google Scholar
PubMed
Search for other papers by Biagio Barone in
Google Scholar
PubMed
Search for other papers by Ciro Imbimbo in
Google Scholar
PubMed
Search for other papers by Felice Crocetto in
Google Scholar
PubMed
CEINGE – Biotecnologie Avanzate Scarl, Naples, Italy
Search for other papers by Monica Dentice in
Google Scholar
PubMed
RGGTCA (R is a purine). Based on their mode of action, they can be subdivided into four different sub-categories: (i) Type I receptors, comprising the AR, the estrogen receptor (ER), and the progesterone receptor (PR), are anchored in the cytoplasm by